What are the recommended screening methods and first‑line treatment options for postpartum depression in breastfeeding mothers?

Postpartum Depression: Screening and Treatment in Breastfeeding Mothers

For screening postpartum depression, use the Edinburgh Postnatal Depression Scale (EPDS) with a cutoff score of 11 or higher, and for first-line treatment in breastfeeding mothers, prescribe sertraline as it transfers to breast milk in the lowest concentrations while being highly effective.

Screening Approach

The EPDS is the gold-standard screening tool for postpartum depression and should be your primary instrument 1. This 10-question assessment generates scores from 0-30, with a cutoff of 11 or higher maximizing both sensitivity and specificity 1. The EPDS has been validated in over 60 languages and demonstrates superior psychometric properties compared to all other screening instruments 1.

When to Screen

• At least once during pregnancy 2
• During the comprehensive postpartum visit (mandatory) 2
• If screened during pregnancy, repeat screening at the postpartum visit 2

The ACOG Committee Opinion explicitly recommends this screening schedule for all obstetric care providers 2. While optimal timing remains somewhat unclear, screening at 2-3 months postpartum captures the peak incidence period 1.

Important caveat: The EPDS screens for depression but does not diagnose it. For definitive diagnosis, psychiatric consultation or the SCID-5 (Structured Clinical Interview for DSM-5) is required, though these are time-consuming and costly 1. In practice, use the EPDS for screening and refer positive screens for diagnostic evaluation.

First-Line Treatment for Breastfeeding Mothers

Pharmacotherapy

Sertraline is the preferred first-line antidepressant for breastfeeding mothers because it achieves the lowest serum medication levels in breastfed infants 3. Paroxetine and fluvoxamine are acceptable alternatives with similarly low breast milk transfer 3.

The evidence strongly supports SSRIs as first-line agents:

• For mild to moderate depression: Either psychotherapy alone OR an SSRI 3
• For moderate to severe depression: Combination of psychotherapy AND medication 3

While sertraline is preferred in breastfeeding, citalopram, escitalopram, and sertraline are considered safest during pregnancy if treatment is needed prenatally 3. Most antidepressants are compatible with breastfeeding, and the benefits of treating maternal depression typically outweigh theoretical risks to the infant 4.

Psychotherapy

Psychotherapy is effective and often preferred by perinatal patients over medications 4. Supportive counseling has demonstrated effectiveness as a treatment strategy 1. However, psychological treatments often remain inaccessible due to provider shortages and systemic barriers 4.

Practical consideration: Virtual care delivery and task-sharing to non-specialist providers can enhance accessibility 4.

Treatment Algorithm

1. Screen with EPDS (cutoff ≥11)
2. If positive screen:
   • Evaluate for bipolar disorder, postpartum psychosis, and suicidal ideation 3
   • Assess severity (mild-moderate vs. moderate-severe)
3. For mild-moderate depression:
   • Offer psychotherapy OR sertraline
   • Patient preference should guide choice
4. For moderate-severe depression:
   • Initiate sertraline (or paroxetine/fluvoxamine if breastfeeding)
   • Arrange psychotherapy concurrently
5. For psychosis, active suicidal thoughts, or thoughts of harming infant:
   • Same-day psychiatric consultation
   • Consider inpatient treatment 3

Treatment Duration

Continue antidepressants for 4-12 months for initial episodes 5. Patients with recurrent depression may benefit from prolonged treatment 5.

Critical Pitfalls to Avoid

• Don't confuse postpartum depression with "baby blues": Baby blues has short duration, mild symptoms, and minimal functional impact 3
• Don't delay treatment due to breastfeeding concerns: The evidence shows sertraline and other preferred SSRIs are safe, and untreated maternal depression has devastating effects on maternal-infant bonding and child development 1, 3
• Don't screen without a plan: Have referral pathways established before implementing screening, as screening alone has limited benefit without treatment initiation or referral 2
• Don't miss bipolar disorder or psychosis: Always evaluate for these conditions in women screening positive for depression 3

Additional Context

Postpartum depression affects 1 in 7 women and is a leading cause of maternal morbidity and mortality 1. It impacts maternal-infant bonding, child development, sleep, fatigue, and maternal physical recovery 1. The condition is underrecognized, making systematic screening essential 6.

For older patients, use a "start low, go slow" approach with preferred agents including sertraline, citalopram, escitalopram, mirtazapine, and venlafaxine 5.